Program at A GlanceCauses and consequences of microRNA dysregulation in cancer Carlo Croce The Ohio State University, USA 14:25-14:50 Molecular diagnosis of lymphomas,from gene expression

4 — 2013 APCC

Program at A Glance

The 22nd AsiA PAcific cAncer conferenceInnovation and Development of Cancer Prevention & Treatment

Thursday October 31, 2013

Time Room Program

08:00-18:00 -------- Registration

Friday November 1, 2013

Time Room Program

08:00-08:30 -------- Registration

08:30-09:00

Banquet Hall

Opening Ceremony

09:00-09:30 Kim Jim-Pok Lectureship

09:30-12:15 Plenary Session

12:30-13:30Studio 1 & 2 Satellite Sessions (Beijing Union Pharmaceutical Factory)

Hubin Hall Satellite Sessions (TTY BIOPHARM Company Limited)

Concurrent Sessions

13:30-17:30

Studio 6 & 8 Gastrointestinal Cancer

Studio 1 & 2 Head and Neck Tumor

Banquet Hall Ⅰ Hematology and Lymphoma

Hubin Hall Radiation Oncology

Hujing Hall Clinical Trial and Cancer Chemotherapy

Banquet Hall Ⅱ Translational Medicine

18:00-20:00 Haihe Hall Asia Pacific Cancer Control Leaders' Summit

2013 APCC — 5

Program at A Glance

Saturday November 2, 2013

Time Room Program

08:00-08:30 -------- Registration

Concurrent Sessions

08:30- 12:00

Haihe Hall Breast Cancer

Hujing Hall Lung Cancer

Studio 6 & 8 Hepatobiliary cancer

Studio 1 & 2 Biotherapy

Hubin Hall Interventional Therapy and Minimally Invasive Therapy

Banquet Hall Ⅰ Gynecologic Cancer

Banquet Hall Ⅱ Urological Cancer

12:00-13:30 Studio 3 APFOCC Executive Committee Meeting & APFOCC General Assembly

12:30-13:30Haihe Hall AstraZeneca Satellite Sessions (Breast Cancer Session)

Hujing Hall AstraZeneca Satellite Sessions (Lung Cancer Session)

Concurrent Sessions

13:30-16:00

Haihe Hall Breast Cancer

Hujing Hall Lung Cancer

Studio 6 & 8 Pancreatic cancer

Studio 1 & 2 Cancer Screening and Prevention

Banquet Hall Ⅰ Oncology Nursing

Banquet Hall Ⅱ Nutrition

Banquet Hall III Cancer Survivor

16:00-17:15Haihe Hall

Plenary Session

17:15-18:00 Closing Ceremony & Young Investigator Award

6 — 2013 APCC

Ancillary Meetings


Opening Ceremony8:30 — 9:00, Friday, November 1, 2013, Banquet Hall, Tianjin Marriott Lakeview Hotel

Asia Pacific Cancer Control Leaders’ Summit18:00 — 20:00, Friday, November 1, 2013, Haihe Hall, Tianjin Marriott Lakeview Hotel

Theme:

Strategy of Cancer Control in Asian Pacific countries

Panel discussion:

Topic 1: Accelerate progress on cancer control in Asia Pacific countries

Topic 2: Reduce cancer burden in Asia Pacific countries

APFOCC Executive Committee Meeting12:00 — 13:00, Saturday, November 2, 2013, Studio 3, Tianjin Marriott Lakeview Hotel

APFOCC General Assembly13:00 — 13:30, Saturday, November 2, 2013, Studio 3, Tianjin Marriott Lakeview Hotel

Closing Ceremony17:15 — 18:00, Saturday, November 2, 2013, Haihe Hall, Tianjin Marriott Lakeview Hotelv

2013 APCC — 7

Plenary Session

9:00 — 12:15, Friday, November 1, 2013Banquet Hall, Tianjin Marriott Lakeview Hotel

Kim Jim-Pok Lectureship9:00-9:30Clinical trials of new anticancer drugs developed in china in recent years

Yan Sun, M.D.Member, Chinese Academy of Engineering, Director, National GCP Center for Anti-Cancer Agents China

9:30-9:55Cancer in the world: the equity imperative

Mary Gospodarowicz, M.D. President, Union for International Cancer Control (UICC)Princess Margaret Hospital, Canada

9:55-10:20Guideline for the clinical practice of prostate cancer

Sien-Shih Chang, M.D. Member, Chinese Academy of Engineering, National Yang-Ming University, Taiwan, China

10:35-11:00National cancer planing

Cary Adams, M.B.A. Chief Executive Officer, Union for International Cancer Control (UICC), Switzerland

11:00-11:25Therapeutic targeting of deletion 5q MDS

Alan F.List, M.D.President, H.Lee Moffitt Cancer Center, USA

11:25-11:50Innovation and development of chemotherapy

Jacqueline Whang-Peng, M.D. Academician, Council of Academia Sinica, Taiwan, China

11:50-12:15A new generation of targeted anti-cancer therapies

Alex Matter, M.D. Fellowship, Swiss Academy for Medical Science, CEO, Experimental Therapeutic Center, Singapore

16:00 — 17:15, Saturday, November 2, 2013Haihe Hall, Tianjin Marriott Lakeview Hotel

16:00-16:25Enhancing targeted therapy by understanding mechanisms of resistance

Webster Cavenee, Ph.D.Director, Ludwig Institute for Cancer Research, San Diego Branch, USA

16:25-16:50 Global progress against cancer, challenges and opportunities

Margaret Foti, M.D.Chief Executive Officer, American Association for Cancer Research, U.S.A.

16:50-17:15Mechanisms of treatment-related symptoms in cancer patients

Charles S. Cleeland, M.D. The University of Texas M. D. Anderson Cancer Center, USA

8 — 2013 APCC

Concurrent Sessions


Gastrointestinal Cancer

13:30 — 17:30, Friday, November 1, 2013

Studio 6 & 8, Tianjin Marriott Lakeview Hotel

Part I: Gastric cancer section

Chairs: Lin Shen, Han Liang

13:35-14:00

Transformation of clinical excellence to patients’

benefit through translational research in gastric

cancer

Sung Hoon Noh

Yonsei University Health System, Yonsei University

College of Medicine, Korea

14:00-14:20

Comprehensive management of gastric cancer in

China

Jiafu Ji

Peking University Cancer Hospital, China

14:20-14:35

An open, multicenter, phase II clinical trial to evaluate

efficacy and safety of S-1 plus cisplatin in patients

with advanced gastric cancer (AGC): HGCSG0702:

preliminary report

Nobuyuki Ehira

Japanese Red Cross Kitami Hospital, Japan

14:35-14:50

Polymorphisms in the microRNA biding-site in the

stem cell marker gene CD133 modify susceptibility to

and survival of gastric cancer

Qiming Wang

Zhengzhou University Affiliated Cancer Hospital,

China

14:50-15:05

Study on association of single nucleotide

polymorphisms and chemotherapy sensitivity in

advanced gastric cancer

Yuan Pan

Tianjin Medical University Cancer Institute and

Hospital, China

15:05-15:20 Q & A

15:20-15:30 Tea Break

Part II: Colorectal cancer section

Chair: Suzhan Zhang

15:35-15:55

Current treatment of liver metastasis from colorectal

cancer in Asia and NECTAR

Cathrine Teh

Manila Medical Center, Philipine

15:55-16:15

Clinical implications of genomic project on colorectal

cancer

Maode Lai

China Pharmaceutical University, China

16:15-16:35

The treatment strategy of peritoneal carcinomatosis

of gastric cancer patients in Korea Cancer Center

Hospital

Jong lnn Lee

Korean Institute of Radiological and Medical Sciences,

Korea

2013 APCC — 9

Concurrent Sessions

16:35-16:55

Treatment strategy and practice of liver metastasis

from colorectal cancer

Peng Zhao


Hospital, China

16:55-17:05

Laparoscopic versus open rectectomy for rectal

cancer: a meta-analysis of results of randomized

controlled trials on recurrence and mortality

Binghong Xiong

Chongqing Medical University, the First Affiliated

Hospital, China

17:05-17:20 Q & A

17:20-17:30 Discussion

Head and Neck Tumor

13:30 — 17:30, Friday, November 1, 2013


Part I

Chairs: Ming Gao, Zhiyuan Zhang

13:35-13:55

The challenges in addressing the West’s fastest

emerging cancer: HPV-related oropharyngeal

carcinoma

Brian O’Sullivan

Princess Margaret Hospital, University of Toronto,

Canada

13:55-14:15

Targeting key apoptosis regulators for new cancer

therapeutics

Shaomeng Wang

University of Toronto, Canada

14:15-14:35

Epigenetic control of head and neck cancer

metastasis

Cunyu Wang

UCLA, Los Angeles, CA, USA

14:35-14:55

Management of metastatic brain tumors

Changhun Rhee

Director General, Korea Cancer Center Hospital,

Korea

14:55-15:15

Functional results of the partial laryngopharyngeal

surgery

Liang Zhou

EENT Hospital of Fudan University, China

10 — 2013 APCC

Concurrent Sessions


15:15-15:25 Q & A

15:25-15:30 Tea Break

Part II

Chairs: Guangyan Yu, Liang Zhou

15:35-15:55

How to train a head neck reconstruction surgeon?

Chenping Zhang

Shanghai Ninth People's Hospital Affiliated Shanghai

Jiao Tong University School of Medicine, China

15:55-16:15

Recent advance of molecular targeted therapy in

metastatic thyroid cancer

Ye Guo

Fudan University Shanghai Cancer Center, China

16:15-16:30

Mislocation and interaction of RET/GFRα4/PSPN

are essential in the progression of human papillary

thyroid cancer

Bayarsaikhan Enkhjargal

National cancer center of Mongolia, Mongolia

16:30-16:45

NIS expression and highly aggressive PTC variants

Xiaolong Li


Hospital, China

16:45-17:00

Multifocality and total tumor diameter predict central

neck lymph node metastases in papillary thyroid

microcarcinoma

Qunzi Zhao

The 2nd Affiliated Hospital Zhejiang University School

of Medicine, China

17:00-17:15

TLR3 signaling promotes metastasis of papillary

thyroid cancer by modulating CD44 expression

through Pl3K/Akt pathway

Dapeng Li

Wuhan Union Hospital, China

17:15-17:30 Q & A

2013 APCC — 11

Concurrent Sessions

Radiation Oncology

13:30 — 17:30, Friday, November 1, 2013

Hubin Hall, Tianjin Marriott Lakeview Hotel

Chairs: Xiaomao Guo, Shengli Ma, Luhua Wang

13:30-13:50

Stereotactic body radiotherapy treatment (SBRT)

Mohamed Ibrahim A Wahid

Pantai Hospital Kuala Lumpur,Malaysia

13:50-14:10

Emerging clinical applications in radiosurgery

John Adler

Stanford University Medical Center,USA

14:10-14:30

Stereotactic ablative radiotherapy for unresectable

hepatocelluar carcinoma patients who are

unsuitable for or after failure of transarterial

chemoembolization

Yeemin Jie

Tri-Service General Hospital, Taiwan, China

14:30-14:50

Treatment of nasopharyngeal carcinoma by

TomoTherapy: five-year experience

Stephen Wan Leung

Yuan's General Hospital, Taiwan, China

14:50-15:10

Individualized radiotherapy: Development and

Challenge

Jinming Yu

Shandong Cancer Hospital, China

15:10-15:30

Stereotactic body radiation therapy in early stage non-

small cell lung cancer

Ping Wang


Hospital, China

15:30-15:40 Tea Break

15:40-15:50

Study of the role of palliative radiotherapy in the

management of incuralbe pedictric malignancies

Prashant Kumbhaj

SMS Medical College, India

15:50-16:00

The relationship between expression of NRAGE,

HDAC3 and NF-κB and radioresistance of esophageal

squamous cell carcinoma

Yanling Yang

The Second Hospital of Hebei Medical University,

China

16:00-16:10

Epigenetic regulation of bdnf gene transcription in

irradiation-induced neurogenesis impairment and

cognitive deficits

Shengjun Ji

The Second Affiliated Hospital of Soochow University,

China

16:10-16:20

Research on regulative Cox-2 and radiosensitivity to

esophageal cancer EC9706 cells

Hui Wu

Affiliated Tumor Hospital of Zhengzhou University,

China

12 — 2013 APCC

Concurrent Sessions


16:20-16:30

The clinical value of contouring clinical target volume

for radiotherapy in locally advanced non-small cell

lung cancer

Jiancheng Li

Fujian Provincial Tumor Hospital, China

16:30-16:40

Dose and volume factors to the acute radiation-

induced heart disease

Jun Wang

The Fourth Hospital of Hebei Medical University,

China

16:40-16:50

Animal study of sodium glycididazole to improve

the effect of radiotherapy for recurrent esophageal

carcinoma

Peipei Wu

Shandong Cancer Hospital and Institute, China

16:50-17:00

The role of radiotherapy in treating patients with

primary malignant mediastinal non-seminomatous

germ cell tumor: A 21-year experience at a single

institution

Jianyang Wang

Cancer Hospital & Institute, Chinese Academy of

Medical Sciences & Peking Union Medical College,

China

17:00-17:10

Which is the optimal threshold for defining functional

lung in SPECT lung perfusion imaging of lung cancer

patients?

Xiuping Ding

Shandong Cancer Hospital and Institute, China

17:10-17:20

Comparative research on the efficacy of cyberknife®

and surgical excision for stage I liver cancer

Zhiyong Yuan


Hospital, China

17:20-17:30

Influence of blocking irradiation-induced autophagy

by Chloroquine on radiosensitivity of esophageal

cancer cells

Xiaoli Yuan

Sichuan Cancer Hospital, China

2013 APCC — 13

Concurrent Sessions

Hematology & Lymphoma

13:30 — 17:40, Friday, November 1, 2013

Banquet Hall I, Tianjin Marriott Lakeview Hotel

Part I: Invited speeches

Chairs: Wenqi Jiang, Jianxiang Wang, Jianyong Li,

Huaqing Wang

13:35-14:00

The developing face of lymphoma genomics

Francesco Bertoni

Oncology Institute of Southern Switzerland,

Switzerland

14:00-14:25

Causes and consequences of microRNA dysregulation

in cancer

Carlo Croce

The Ohio State University, USA

14:25-14:50

Molecular diagnosis of lymphomas,from gene

expression to next generation sequencing

Timothy Greiner

University of Nebraska Medical Center, USA

14:50-15:15

Why Bortezomib cannot go with ‘green’?

Li Jia

Centre for Haemato-Oncology Barts Cancer

Institute,University of London,UK

15:15-15:30

Recent advances in the diagnosis and treatment of

NK/T cell Lymphoma

Huiqiang Huang

Sun Yat-Sen University Cancer Center, China

15:30-15:45

Epigenetics in lymphoma: exploring novel diagnosis

biomarkers and therapeutic approaches

Xi Wang

Tianjin Medical University,China

15:45-15:55 Q & A

15:55-16:05 Tea Break

Part II: Free paper

Chairs: Yizhuo Zhang, Daobin Zhou, Huiqiang

Huang, Lugui Qiu

16:10-16:20

The function and pathogenesis of a novel fusion gene

TBLR1-RARα in acute promyelocytic leukemia

Yirui Chen

Chinese Academy of Medical Sciences & Peking Union

Medical College, China

16:20-16:30

Expression of BAFF and BAFF-R in follicular

lymphoma: correlation with clinicopathologic

characteristics and survival outcomes

YaJun Li

Sun Yat-Sen University Cancer Center, China

16:30-16:40

BTK inhibitor PCI-32765 targets endogenous and

microenvironment-mediated B-cell receptor signaling

to suppress lymphoma cell growth and is highly

synergistic with Bortezmib against non-Hodgkin B-cell

lymphomas

Fulian Qu


Hospital, China

14 — 2013 APCC

Concurrent Sessions


16:40-16:50

Transfection of chimeric anti-CD138 gene enhances

natural killer cell line NK-92MI activation and killing

of multiple myeloma cells

Hua Jiang

Myeloma & Lymphoma Center, Changzheng Hospital,

The Second Military Medical University, China.

16:50-17:00

Outcomes of unrelated umbilical cord blood

transplantation using a conditioning regimen of TBI/

Ara-c/CY without ATG for adolescent and adults

patients with high-risk hematologic malignancies

Zimin Sun

Anhui Provincial Hospital/Anhui Medical University,

China

17:00-17:10

Characteristics of NOTCH1 mutation in adult T-cell

acute lymphoblastic leukemia

Zheng Ge

The First Affiliated Hospital of Nanjing Medical

University, China

17:10-17:20

Fast STR-PCR protocol enabling rapid and high

quality chimerism analysis after allo-HSCT

Hongxing Liu

Ludaopei Hematology & Oncology Center, Hebei

Yanda Hospital, China

17:20-17:30

The effect of containing ATG conditioning regimen

on the relapse in adult patients with aggressive T cell

lymphomas after allogeneic hematopoietic stem cell

transplantation

Jun Yang

Shanghai Jiaotong University affiliated Shanghai First

Peoples Hospital, China

17:30-17:40

Do patients with primary non-Hodgkin’s lymphoma of

female genital tract have high risk of CNS relapse?

Xinxin Cao

Peking Union Medical College Hospital, Chinese

Academy of Medical Sciences & Peking Union Medical

College, China

2013 APCC — 15

Concurrent Sessions

Clinical Trail & Cancer Chemotherapy

13:30 — 17:30, Friday, November 1, 2013

Hujing Hall, Tianjin Marriott Lakeview Hotel

Part I

Chairs: Wenqi Jiang, Yi Ba

13:35-13:55

Anticancer drug clinical trials in China

Yuankai Shi

Cancer Institute & Hospital, Chinese Academy of


China

13:55-14:00 Q&A

14:00-14:20

Pharmaceutial R & D in China

Dayao Zhao

Janssen Pharmaceutical Research & Development,

China

14:20-14:25 Q&A

14:25-14:45

Trends in anti-cancer drug research in China

Yinxiang Wang

Zhejiang Beta Pharma, Inc. ( ZBPI), China

14:45-14:50 Q&A

15:00-15:07

Subsequent cancer risks of patients with epilepsy:a

nation-wide epidemiological study from Sweden

Xinjun Li

Lund University, Sweden

15:08-15:14

The comparative analysis of preoperative stage and

postoperative stage for esophageal carcinoma

Xue Qiao

Second Affiliated Hospital of Soochow University,

China

15:15-15:20

Cetuximab in combination with chemoradiotherapy in

Chinese patients with non-resectable, locally advanced

esophageal squamous cell carcinoma: A prospective,

multicenter phase II trail

Xue Meng

Shandong Cancer Hospital and Institute, Jinan, China

15:20-15:30 Tea Break

Part II

Chairs: Yuankai Shi, Kai Li

15:35-16:00

The role of molecular markers in guiding therapy for

oligodendroglioma

Jan Buckner

Mayo Clinic, USA

16:00-16:05 Q&A

16:05-16:25

Early diagnosis and chemotherapy of gastric cancer

Yi Ba

Tianjin medical university cancer institute and

hospital, China

16:25-16:30 Q&A

16 — 2013 APCC

Concurrent Sessions


16:30-16:37

Clinical analysis of carcinoid: A report of 414 cases

from a single centre

Yong Tang


Hospital, China

16:37-16:44

Chidamide: A novel epigenetic therapy as an effective

single agent treatment in patients with relapsed or

refractory peripheral T-cell lymphoma

Yuankai Shi



China

16:44-16:51

Effects of Rifampin on the Pharmacokinetics of

Lenvatinib in Healthy Subjects

Robert Shumaker

Eisai Inc., Woodcliff Lake, NJGA Thompson

Consulting, Cincinnati, OH,USA

16:51-16:58

A novel CRM1 inhibitor targeting for NSCLC with

EGFR-TKI resistance mutation

Shuai Wang

Cancer Institute/Hospital, Chinese Academy of


China

16:58-17:05

Generation and biological character analysis of EGFR-

TKI resistant cell line

Xiaohong Han

Cancer Institute/Hospital, Chinese Academy of


China

17:05-17:13

A new biomarker heat shock protein 90 alpha as

therapeutic monitor and predictor for lung cancer

patients

Yuankai Shi



China

17:13-17:20

Phase Ⅰ study of nimotuzumab combined with

postoperative chemoradiotherapy in Chinese patients

with malignant glioma

Wenbin Li, Jing Chen

Beijing Tiantan Hospital affiliated to Capital Medical

University, China

17:20-17:30 Tea Break

2013 APCC — 17

Concurrent Sessions

Translational Medicine

13:30 — 17:30, Friday, November 1, 2013

Banquet Hall II, Tianjin Marriott Lakeview Hotel

Chairs: Qimin Zhan, Ning Zhang

13:35-13:55

Anti-tumor effects of Alarmins

Joost Oppenheim

Center for Cancer Research, National Cancer

Institute,USA

13:55-14:00 Q&A

14:00-14:20

Selective killing of oncogenic stem cells in cancer

chemoprevention

Lin Zhang

University of Pittsburgh Cancer Institute, USA

14:20-14:25 Q&A

14:25-14:45

Integrated genomics: impact on personalized cancer

medicine

Wei Zhang

University of Texas M.D.Anderson Cancer Center, USA

14:45-14:50 Q&A

14:50-15:10

Regenomics on intractable diseases: enhanced repair

of myocardial infarction via scaffold-supported

transepicardial delivery of resident cardiac stem

cells

Seungjin Lee

Ewha Womans University, Korea

15:10-15:15 Q&A

15:15-15:35

UHRF1 regulates Hedgehog signaling to in basal cell

carcinoma

Zhongjun Zhou

Department of Biochemistry, Li Ka Shing Faculty of

Medicine, The University of Hong Kong, China

15:35-15:40 Q&A

15:40-15:50 Tea Break

15:50-16:10

Dysregulated cell cycle regulators in tumorigenesis

and metastasis

Qimin Zhan

State Key Laboratory of Molecular Oncology, Cancer

Institute, Chinese Academy of Medical Sciences, China

16:10-16:15 Q&A

16:15-16:35

NIR triggered hematoporphyrin-based drug delivery

system for drug resistance reversal and ultra tumor

ablation

Ning Zhang

Tianjin Medical University, China

16:35-16:40 Q&A

16:40-17:00

Targeted delivery of PLK1-siRNA by ScFv suppresses

Her2+ breast cancer growth and metastasis

Erwei Song

Breast Tumor Center, Sun Yat-sen Memorial Hospital,

Sun Yat-sen University, Guangzhou, China

17:00-17:05 Q&A

18 — 2013 APCC

Concurrent Sessions


17:05-17:25

MicroRNA-26a: a novel prognostic marker and

therapeutic target for HCC

Lunxiu Qin

Liver Cancer Institute & Zhongshan Hospital, Fudan

University, China

17:25-17:30 Q&A

Breast Cancer

8:30 — 16:00, Saturday, November 2, 2013

Haihe Hall, Tianjin Marriott Lakeview Hotel

8:30-8:40 Opening ceremony

Chair: Jin Zhang

Special guests: Shuling Li, Zhenzhou Shen, Jiaqing

Zhang

8:40-9:10

Invited keynote presentation

Chairs: Binghe Xu, Guosheng Ren

Trends and strategies of treatment of early stage breast

cancer

Zhimin Shao

Fudan University Cancer Hospital, China

Part I: Epidemiology and surgery

Chairs: Santai Song, Bin Zhang, Zhiyi Fang

9:10-9:30

Current trends of breast reconstruction after

mastectomy for breast cancer patients in China

Jiong Wu


9:30-9:50

Personalized breast cancer surgery in Seoul National

University Cancer Hospital

Dong Young Noh

Seoul National University Hospital, Korea

9:50-10:10

NKILA is an indispensable third wheel of the NFκB/

IκB complex in breast cancer cells

Erwei Song

Sun Yat-sen Memorial Hospital, China

2013 APCC — 19

Concurrent Sessions

10:10-10:40 Q & A

Chair: Da Pang

Expert Group: Xiang Wang, Shude Cui,

Hongyuan Li, Chengyu Luo, Qi Wang, Suisheng Yang,

Zhangjun Song

10:40-10:50 Tea Break

Part II: Targeting therapy

Chairs: Shenming Wang, Jun Jiang, Lin Gu

10:50-11:10

The chemical therapy progress of breast cancer

Binghe Xu

Cancer Institute&Hospital, Chinese Academy of

Medical Sciences, China

11:10-11:30

Single cell analysis of gene copy number changes in

breast cancer diagnostics

Anders Zetterberg

Karolinska Institute, Sweden

11:30-11:50

The management of patients with advanced breast

cancer

Zefei Jiang

Military Medical Academy Hospital, China

11:50-12:20 Q & A

Chair: Jinhai Tang

Expert Group: Qingyuan Zhang, Xiaojia Wang,

Jian Liu, Hong Zheng, Ling Jia, Qiang Zou,

Jianghua Ou

Part III: Endocrine therapy

Chairs: Mingtian Yang, Yongsheng Wang

12:20-12:40

Endocrine therapy in premenopausal breast cancer

Tao OuYang

Beijing Cancer Hospital , China

12:40-13:00

The endocrine therapy of advanced breast cancer

Ning Liao

Guangdong General Hospital , China

13:00-13:20 Q & A

Chair: Qiang Sun

Expert Group: Donggeng Liu, Xuening Duan,

Cuizhi Geng, Shui Wang, Hongjian Yang, Yali Cao,

Benzhong Wang

13:20-13:30 Tea Break

Part IV: Individualized and comprehensive therapy

Chairs: Fengxi Su, Yinhua Liu, Xuchen Cao

13:30-13:50

Deregulation of cancer energy hallmark during

tumorigenesis

Mong Hong Lee

M.D. Anderson Cancer Center, Houston USA

13:50-14:10

MRE11, a core protein of DNA double strand break

(DSB) repair protein in breast cancer

Mingfeng Hou

Kaohsiung Medical University Hospital, Kaohsiung,

Taiwan, China

20 — 2013 APCC

Concurrent Sessions


14:10-14:30

Molecular typing and drug treatment of early breast

cancer

Xichun Hu


14:30-14:50 Q & A

Chair: Zhongsheng Tong

Expert Group: Pin Zhang, Feng Jin,Zhimin Fan,

Xi Wang, Jianjun He, Yu Wang, Dahua Mao

Part Ⅴ : Diagnosis, radiotherapy and basic researches

Chairs: Kunwei Shen, Xiaoming Xie, Duo Ni

14:50-15:10

Would radiation dose-volume of cardiac structure has

an impact on early cardiac toxicity in HER-2 positive

breast cancer receiving concurrent trastuzumab and

adjuvant radiotherapy?

Jiayi Chen


15:10-15:25

The treatment of patients with advanced breast

cancer

Huiping Li

Beijing Cancer Hospital, China

15:25-15:40

Diagnosis of breast lesions with dynamic contrast-

enhanced MR imaging, DWI, and 1H MR spectroscopy

Peifang Liu


Hospital, China

15:40-15:55

A Phase III, open-label, randomized, multicenter study

of eribulin mesylate versus capecitabine in patients

with locally advanced or metastatic breast cancer

previously treated with anthracyclines and taxanes

Peter A. Kaufman

Dartmouth-Hitchcock Medical Center Hematology/

Oncology One Medical Center Drive Lebanon, USA

15:55-16:00

The summary speech of breast cancer Concurrent

Session

Chairman: Jin Zhang

2013 APCC — 21

Concurrent Sessions

Lung Cancer


Hujing Hall, Tianjin Marriott Lakeview Hotel

8:00-8:10

welcome and introduction (Changli Wang)

Part I: Surgical Treatment of Lung Cancer

Chairs: Qinghua Zhou, Qibin Song

08:10-08:30

Individualized surgical treatment for locally advanced

non-small cell lung cancer based on molecular

biomarkers

Qinghua Zhou

Tianjin Medical University General Hospital, China

08:30-08:50

Completely thoracicoscopic lobectomy for lung

cancer: China experience and initial results

Jun Wang

Peking university, People’s hospital, China

08:50-09:05

Prognostic factors in resected non-small cell lung

cancer

Dongsheng Yue


Hospital, China

09:05-09:20

HOPX is methylated and exerts tumor suppressive

function through Ras-induced senescence in human

lung cancer

Yuan Chen

Institute of Pathology, University Hospital Jena,

Friexrich Schiller University Jena, Germany


9:30-9:40 Tea Break

Part II: Diagnosis and Test

Chairs: Shun Lu, Cheng Huang

09:40-10:00

Assessment of antiangiogenic agents in non-small cell

lung cancer

Zhaoxiang Ye


Hospital, China

10:00-10:20

Test of molecular marker for lung cancer

Terufumi KATO

Japan

10:20-10:40

EGFR and ALK gene testing in NSCLC

Xuan Zeng

Peking XieHe Hospial, Chinese academy of medical

sciences, China

10:40-11:00

Liquid biopsy-based biomarker detection in small-cell

lung cancer

Ying Cheng

Ji Lin Cancer hospital, China

11:00-11:20

Advances and significance of blood based whole

genomic analysis for advanced lung cancer

Jie Wang

Peking university, Cancer hospital, China

22 — 2013 APCC

Concurrent Sessions


11:20-11:40

Driven genes and translational research in lung

cancer

Shun Lu

Shanghai Chest Hospital, China

11:40-11:55

Correlation between Coxsachievirus and lung cancer

development

Zhongli Zhan


Hospital, China


12:05-13:10 Special speech

Part III: Development of Treatment and Research for Lung Cancer

Chairs: Kai Li, Baohui Han

13:30-13:50

Development of surgical treatment of non-small cell

lung cancer

Heng Zhao


13:50-14:10

Development of molecular targeted therapy for NSCLC

in China

Yuankai Shi

Cancer Institute &Hospital, Chinese Academy of


14:10-14:30

Development of second line treatment of NSCLC:

Need to detect driven gene mutation status

Baohui Han


14:30-14:50

Effect of postoperative 3D-conformal radiotherapy

(3DCRT) for patients with p Ⅲ A-N2 non-small-

cell lung cancer (NSCLC) after complete resection

and adjuvant chemotherapy: interim analysis of a

prospective phase Ⅲ study

Lvhua Wang

Cancer Hospital & Institute, Chinese Academy of


14:50-15:10

JAK/STAT3 signaling is essential for TGF-β-induced

epithelial -mesenchymal transition in lung cancer cells

Hongtao Zhang

Soochow University Laboratory of Cancer Molecular

Genetics, medical College of Soochow University, Su

Zhou, China

15:10-15:30

MiR-26a enhances metastasis potential of lung cancer

cells via AKT pathway by targeting PTEN

Ke Xu

Tianjin Lung Cancer Institute, Tianjin Medical

University General Hospital, China


15:40 adjourn

2013 APCC — 23

Concurrent Sessions

Hepatobiliary Cancer



Part I

Chairs: Jia Fan, Jiahong Dong

08:30-09:00

Research on molecular pathological mechanism of

HCC.

Xinwei Wang

Center for Cancer Research National Cancer Institute,

USA

09:00-09:30

Progresses in clinical therapy of liver cancer.

Qiang Li

Tianjin Medical University Cancer Institute&Hospital,

China

9:30-9:45 Q & A

9:45-10:00 Tea Break

Part II

Chairs: Shenglong Ye, Jian Zhou

10:00-10:30

Perihilar liver resection for hilar

cholangiocarcinoma.

Jiahong Dong

Chinese PLA General Hospital, China

10:30-11:00

Interpretation of the new TNM classification of biliary

tract tumor.

Xiaoqing Jiang

Eastern Hepatobiliary Surgery Hospital;Institute of

Oriental Hepatobiliary Surgery, China

11:00-11:30

Transcatheter arterial chemoembolization on liver

cancer: current status and challenges.

Gaojun Teng

Zhongda Hospital Southeast University, China

11:30-11:45 Q & A

24 — 2013 APCC

Concurrent Sessions


Biotherapy



Chairs: Bo Huang, Xiubao Ren

8:35-9:00

Cancer vaccines and immunotherapy: basic principles

and translation to clinical trials

Jay Berzofsky

NCI, USA

9:00-9:25

Immune elements reshape cancer stemness and

invasiveness

Weiping Zou

Michigan University, USA

9:25-9:50

Changing tumor microenvironment by local radiation

and modified antibody

Yangxin Fu

University of Chicago, USA

9:50-10:15

Myeloid-derived suppressor cells in tumor immune

escape

Qingqing Wang

Zhejiang University, China

10:15-10:35 Tea Break

10:35-11:00

Microparticles: a road to antitumor immunity

Bo Huang

Chinese Academy of Medical Sciences, China

11:00-11:25

HDAC inhibition promotes sustained tumor regression

in the context of oncolytic immunotherapy

Yonghong Wan

McMaster University,Canada

11:25-11:40

Small GTPase RBJ mediates nuclear entrapment of

MEK1/2 in tumor progression

Taoyong Chen

Second Military Medical University, China

11:40-11:55

Enhanced nasal mucosal delivery and immunogenicity

of anti-caries DNA vaccine through incorporation of

anionic liposomes in chitosan/DNA complexes

Xiangliang Yang

Huazhong University of Sciences and Technology,

China

2013 APCC — 25

Concurrent Sessions

Interventional Therapy and Minimally Invasive Therapy


Hubin Hall, Tianjin Marriott Lakeview Hotel

Part I

Chairs: Renjie Yang, Peihong Wu

8:30-8:50

Minimally invasive therapy and combination with

other multi-subjects in oncology

Peihong Wu

Sun Yat-sen University Cancer Center, China

8:50-9:10

Palliative treatment of malignant trachea-bronchial

stenosis with metallic stents

RenJie Yang

Beijing University Cancer Hospital,China

9:10-9:30

CT-guided percutaneous cryoablation of bone

tumors

Yueyong Xiao

Chinese PLA General Hospital, Beijing, China

9:30-9:50

In vitro model to estimate the effects of 125I seeds on

cancer cells

Fujun Zhang

Sun Yat-sen University, Guangzhou, China

9:50-10:10

The PMWA of lung tumor

Weijun Fan


10:10-10:30

Interventional treatment and target treatment of

gastrointestinal tumors

Xu Zhu

Beijing University Cancer Hospital, Beijing, China

Part II

Chairs: Zhi Guo, Fujun Zhang

10:30-10:50

Radiofrequency ablation and radiofrequency ablation

combined with TACE versus surgical resection for

small hepatocellular carcinoma: a Meta-analysis

Chuansheng Zheng

Huazhong University of Science and Technology,

China

10:50-11:10

Transarterial chemoembolization with gelatin sponge

particles for hepatocellular carcinoma: safety and

efficacy

Yuewei Zhang

Affiliated Zhongshan Hospital of Dalian University,

China

11:10-11:30

The effect of cytotoxic activity of anticancer drugs

on hepatocellular carcinoma cells in hypoxic-

hyponutritional culture

Qiang Li


11:30-11:50

A retrospective study of intervention treatment for

72 cases of gastric cancer with liver metastasis after

failure venous chemotherapy

Peng Liu


26 — 2013 APCC

Concurrent Sessions


11:50-12:00

CT-guided percutaneous microwave ablation of

adrenal malignant carcinoma

Xin Li

Sun Yat-sen University, China

12:00-12:10

Clinical therapeutic effect observation of

arsenic trioxide combined transcatheter arterial

chemoembolization in treating patients of primary

liver cancer with pulmonary metastases

Hongtao Hu

Henan Cancer Hospital, China

Gynecologic Cancer



08:30-09:00

The management of recurrent ovarian epithethelial

cancer: the opproach of indication and

contraindication for second cytoreductive surgery and

choice for chemotherapeutic agents

Xiugui Sheng

Shandong Tumor hospital,China

09:00-09:35

Abdominal radical trachelectomy (ART) for cervical

malignancies: surgical, oncological and fertility

outcomes in 156 patients

Xiaohua Wu

Fudan University Shanghai Cancer Center, China

09:35-10:10

Rsf-1, a chromatin remodeling protein, interacts with

cyclin E1 and promotes tumor development

Jim Jinn-Chyuan Sheu

China Medical University Taiwan, China

10:10-10:25 Tea Break

10:25-10:35

Evaluation of health utility in survivors of locally

advanced cervical cancer

Soehartati Gondhowiardjo

University of Indonesia, Indonesia

10:35-10:45

Factors influencing uptake of cervical cancer screening

among women in India: a pilot study

S. Badaya

M.B.B.S (Intern), Gajra Raja Medical College, Gwalior,

India

2013 APCC — 27

Concurrent Sessions

10:45-10:55

Construction of CDK7 siRNA expression vector and

effects on the cisplatin sensitivity of endometrial

carcinoma cell

Wenxin Liu


Hospital,China

10:55-11:05

Clinicopathological factors associated with para-

aortic lymph node metastasis in endometrioid

endometrial adenocarcinoma: a consecutive study of

689 Patients

Boer shan

Department of Gynecologic Oncology, Fudan

University Shanghai Cancer Center, China

11:05-11:15

A prospective 212 case study of SLN biopsy for

assessing the pelvic nodal status in early-stage cervical

cancer

Dapeng Li

Shandong Tumor hospital,China

11:15-11:25

Rectal late side effects are determined by dose–volume

parameters computed tomography image–guided

brachytherapy for locally advanced cervical cancer of

China

Yongchun Zhou

Department of Radiation Oncology, Xijing Hospital,

Fourth Military Medical University, China

11:25-11:35

Expression of Fli-1 was associated with the prognosis

of endometrial cancer

Wei Song

Cancer center, The First Hospital, Jilin University,

China

11:35-11:45 Q & A

Urological Cancer



Part I

Chairs: Xin Yao, Changlin Li

8:25-8:30

Opening presentation

Yanqun Na

Peking University Shougang Hospital, China

8:30-9:00

Talk 1 Asian trend of primary androgen depletion

therapy on the prostate cancer

Hideyuki Akaza

Department of Strategic investigation on

comprehensive cancer network

Research Center for Advanced Science and Technology

The University of Tokyo, Japan

9:00-9:30

Oncocytic hybrid tumors associated with Birt-Hogg-

Dubé (BHD) syndrome

Xming Yang

Department of Pathology, Northwestern University

Feinberg School of Medicine, Chicago, USA

9:30-10:00

Circulating tumor cells in kidney cancer

Minhan Tan

Institute of Bioengineering and Nanotechnology,

Singapore

10:00-10:30

To be determined

Dingwei Ye

Fudan University Shanghai Cancer center, China

28 — 2013 APCC

Concurrent Sessions


Part II

Chairs: Dingwei Ye, Ningchen Li

10:40-10:55

Optimal surgical margin in nephron-sparing

surgery for T1b renal cell carcinoma

Xusheng Chen

Tianjin Medical University, Cancer Institute and

Hospital, China

10:55-11:10

The effects of G250 promoter controlled conditionally

replicative adenovirus expressing Ki67-siRNA on renal

cancer cell in vitro

Jiacun Chen

Affiliated Hospital of Xuzhou Medical College, China

11:10-11:25

The prediction of extraprostatic extension in patients

with clinically organ-confined prostate cancer

Qing Zhang

The Sixth Hospital of Shanghai Jiao Tong University,

China

11:25-11:40

Preliminary study of the anti-tumor effect of human

cord blood monocytes induced by mouse stromal cells

for renal cell carcinoma

Jian Wang

Affiliated Hospital of Guangdong Medical College,

China

Pancreatic Cancer



Chairs: Quanxing Ni, Jihui Hao

13:35-13:55

Molecular targeting treatment of pancreatic cancer

Min Li

The University of Texas Medical School at Houston,

Houston, USA

13:55-14:15

Optimization of pancreaticojejunostomy in

pancreaticoduodenectomy when treating resectable

pancreatic cancer

Xianjun Yu

Fudan University Shanghai Cancer Center, Shanghai,

China

14:15-14:25

A new approach for evaluating the resectability of

pancreatic cancer

Huaizhi Wang

Southwest Hospital, Third Military Medical University,

Chongqing, China

14:25-14:35

Characteristics of lymph node metastasis in pancreatic

head cancer

Deliang Fu

Huashan Hospital, Shanghai Medical College, Fudan

University, Shanghai, China

14:35-14:45

Surgical approches to pancreatic cancer

Mokenge Malafa

H. Lee Moffitt Cancer Center,Tampa, Florida, USA

2013 APCC — 29

Concurrent Sessions

14:45-14:55

The role of Hypoxia-inducible factor-1α in pancreatic

cancer

Jihui Hao


Hospital, Tianjin, China

14:55-15:10 Q & A

15:10-15:20 Tea Break

Nutrition



Chair: Hanping Shi

13:30-14:00

Improving results of cancer therapies with clinical

nutrition

Jonathan M. Asprer

University of Santo Tomas Hospital, Philippines

14:00-14:30

Effects of antioxidants of special nutrient VIUSID on

oxidative stress

Eduardo Sanz

New York University & Catalysis S.A.Company, USA

14:30-15:00

Energy metabolism and normal nutritional

demands

Wei Li

The First Affiliated Hospital, Jilin University, China

15:00-15:30

Nutrition therapy for patients with cachexia

Kang Yu

Peking Union Hospital, China

15:30-16:00

Current status and future development of cancer

nutrition in China

Hanping Shi

The First Affiliated Hospital, Sun Yat-sen University,

China

30 — 2013 APCC

Concurrent Sessions


Prevention



Chair: Weicheng You

13:30-13:50

Global and local cancer control strategy in Asia

Kazuo Tajima

Mie University Hospital, Japan

13:50-14:10

Changing patterns of cancer incidence & treatment in

Korea: How to improve cancer research & control

Jae Kyung Roh

Yonsei University College of Medicine, Korea

14:10-14:30

Association of tobacco smoking and body mass index

with risk of total and cause-specific deaths in Asia

Wei Zheng

Vanderbilt University, USA

14:30-14:50

Impact of cancer prevention from molecular epidemiology

Daehee Kang

Seoul National University College of Medicine, Korea

14:50-15:10

Assessment of breast screening program in China

Kexin Chen

Tianjin University Cancer Hospital & Institute, China

15:10-15:30

Gastric cancer prevention by eradication of H. pylori

at high-risk population in Linqu County, China

Weicheng You

Peking University Cancer Hospital & Institute, China

15:30-16:00 Q & A

Oncology Nursing



Part I

Chairs: Bo Xu, Yongqin Jiang

13:35-14:05

Journey to oncology nursing excellence

Mary Gullatte

Oncology Nursing Society (ONS), USA

14:05-14:35

The importance and functions of evidence-based

health care center

Peifen Mu

Yangming University, Taiwan, China

14:35-15:05

The influence of spirit nursing care model on social

support and quality of life in elderly patients with

tumors

Yongyi Chen

Hunan Tumor Hospital, China

Part II

Chairs: Yongyi Chen, Huiying Qin

15:05-15:20

The relationships between symptom distress and

coping strategy in esophageal cancer patients

undergoing postoperative adjuvant chemotherapy

Xiaodan Wu


2013 APCC — 31

Concurrent Sessions

15:20-15:35

Investigation of sexuality and relative education

received for currently treated cancer patients

Wanmin Qiang

Tianjin Medical University Cancer Hospital, China

15:35-15:50

The innovation and practice of oncology nursing in

China

Bo Xu

Chinese Academy of Medical Science Cancer Hospital,

China

15:50-16:00 Q & A

Cancer Survivor


Banquet Hall III, Tianjin Marriott Lakeview Hotel

Part I: Patient Group Experience Change

13:00-13:05

Intro

Yin Qin

The Chinese Anti-Cancer Association

13:05-13:10

Welcome Note

Yin Wang


13:10-13:20

Patient Group Management

Anli Shi


13:20-13:30

Patient Eductation in Oncology

Xiuyi Zhi


13:30-13:40

Patient Group Experience Change Part 1

Delegate

CCRS-Neimeng Rehabiliation Group

13:40-13:50


Delegate

CCRS- JiangSu Rehabiliation Group

32 — 2013 APCC

Concurrent Sessions


13:50-14:00


Zhengpin Yuan

CCRS- Shanghai Rehabiliation Group

14:00-14:15 Tea Break

Part II: Patient Documentary Awarding Ceremony

14:15-14:20

Awarding Ceremongy Opening

Yin Qin


14:20-14:25

Awarding 'Best Producer'

Duanqi Liu


14:25-14:30

Awarding 'Best Director'

Yuankai Shi


14:30-14:35

Awarding 'Best Documentary Short'

Xiuyi Zhi


14:35-14:40

Awarding 'Best Leading Star'

Ying Wang, Anli Shi


14:40-14:55

Showcasing ' Best Documentary Short'

14:55-15:00

Closing Note

Anli Shi


Program at A GlanceCauses and consequences of microRNA dysregulation in cancer Carlo Croce The Ohio State University, USA 14:25-14:50 Molecular diagnosis of lymphomas,from gene expression

Documents